These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6684448)

  • 21. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M; Steinhoff M; Schneider D; Luger TA
    Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prescription and surveillance of steroidal and non-steroidal anti-inflammatory agents. Prescription and surveillance of a dermocorticoid treatment].
    Bonnetblanc JM; Chosidow O; Grosshans E
    Ann Dermatol Venereol; 2002 Oct; 129(10 Suppl):S157-61. PubMed ID: 12718145
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-inflammatory and immunosuppressive effect of glucocorticoids. What are the basic molecular mechanisms?].
    Petzoldt D; Krutmann J
    Hautarzt; 1996 Feb; 47(2):166-8. PubMed ID: 8868463
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of esterification on the topical antiinflammatory activity of 7 alpha-chloro- and 7 alpha-bromo-16 alpha-methylprednisolones.
    Green MJ; Shue HJ; Tiberi R; Berkenkopf J; Fernandez X; Monahan M; Lutsky BN
    Arzneimittelforschung; 1980; 30(10):1618-20. PubMed ID: 7192095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Medeiros R; Otuki MF; Avellar MC; Calixto JB
    Eur J Pharmacol; 2007 Mar; 559(2-3):227-35. PubMed ID: 17258194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phosphodiesterase 4 inhibitor AWD 12-281 is active in a new guinea-pig model of allergic skin inflammation predictive of human skin penetration and suppresses both Th1 and Th2 cytokines in mice.
    Hoppmann J; Bäumer W; Galetzka C; Höfgen N; Kietzmann M; Rundfeldt C
    J Pharm Pharmacol; 2005 Dec; 57(12):1609-17. PubMed ID: 16354405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory effects of topical supernatant from human amniotic membrane cell culture on canine deep corneal ulcer after human amniotic membrane transplantation.
    Wichayacoop T; Briksawan P; Tuntivanich P; Yibchok-Anun S
    Vet Ophthalmol; 2009; 12(1):28-35. PubMed ID: 19152595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of glucocorticosteroids on the skin and eye.
    Beltrani VS; Barsanti FA; Bielory L
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):557-80. PubMed ID: 16054543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents.
    Rhodes LE; Diffey BL
    Br J Dermatol; 1997 Jan; 136(1):12-7. PubMed ID: 9039288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical steroid treatment in infants, children, and adolescents.
    Hepburn D; Yohn JJ; Weston WL
    Adv Dermatol; 1994; 9():225-54; discussion 255. PubMed ID: 8060739
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dermatologic topical corticosteroids. Principles and usage standards, posology].
    Ann Dermatol Venereol; 2000 Oct; 127(Spec No 1):A180-5. PubMed ID: 11474520
    [No Abstract]   [Full Text] [Related]  

  • 32. [Topically administered glucocorticosteroids. Part 2: Dose effect--preparations].
    Niedner R
    Fortschr Med; 1992 Jun; 110(18):345. PubMed ID: 1644395
    [No Abstract]   [Full Text] [Related]  

  • 33. [Percutaneous absorption of triamcinolone 16 alpha, 17 alpha cyclopentylene-dioxy-21-acetate (author's transl)].
    Meynadier J; Guilhou JJ; Peyron JL
    Dermatologica; 1981; 162(5):336-41. PubMed ID: 7250468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and topical antiinflammatory potencies of a series of 6-keto- and delta 6-6-acyloxybetamethasone derivatives.
    Draper RW; Berkenkopf J; Carlon E; Fernandez X; Monahan M; Lutsky BN
    Arzneimittelforschung; 1982; 32(4):317-22. PubMed ID: 7201799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of short-term topical corticosteroid treatment on mucosal enzyme systems in patients with distal inflammatory bowel disease.
    Scheurlen C; Allgayer H; Hardt M; Kruis W
    Hepatogastroenterology; 1998; 45(23):1539-45. PubMed ID: 9840102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical corticosteroids.
    Katz HI
    Dermatol Clin; 1995 Oct; 13(4):805-15. PubMed ID: 8785885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
    Henschel V; Jaminet F
    J Pharm Belg; 1974; 29(1):3-15. PubMed ID: 4831715
    [No Abstract]   [Full Text] [Related]  

  • 39. Bioavailability of proprietary corticosteroid containing ointments.
    Trikam DS; Morton DJ
    Cent Afr J Med; 1985 Mar; 31(3):57-8. PubMed ID: 4016908
    [No Abstract]   [Full Text] [Related]  

  • 40. [Microbiological studies of a corticoid cream prepared under sterile conditions and lacking nitrogenous compounds].
    Carlone NA
    G Batteriol Virol Immunol; 1977; 70(1-6):94-9. PubMed ID: 350685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.